Recombinant immunotoxins achieve complete and durable tumor regression in a myeloma mouse model April 9, 2019
AstraZeneca PI3Kgamma inhibitor AZD-3458 reverts tumor resistance to immunotherapy in vivo April 8, 2019
United Therapeutics discontinues development of esuberaprost based on BEAT results in PAH April 8, 2019
RSS